Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001708138-20-000108

EVP Research sold 6,628 shares at an average $542.73 ($3,597,188)

  • EVP Research gave up 7,108 shares (to pay taxes)
  • EVP Research acquired 13,736 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

MURPHY ANDREW J · EVP Research

Table I: Non-derivative

21 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-16 Exercise or conversion : show line 1 in the form +13,736 $30.63 $420,734 60,872 D
2020-11-16 Shares withheld for taxes : show line 2 in the form −7,108 $561.39 $3,990,360 53,764 D
2020-11-17 Sale : show line 3 in the form −743 $536.68 $398,753 53,021 D
2020-11-17 Sale : show line 4 in the form −229 $537.38 $123,060 52,792 D
2020-11-17 Sale : show line 5 in the form −591 $538.37 $318,177 52,201 D
2020-11-17 Sale : show line 6 in the form −42 $539.87 $22,675 52,159 D
2020-11-17 Sale : show line 7 in the form −1,442 $540.49 $779,387 50,717 D
2020-11-17 Sale : show line 8 in the form −812 $541.42 $439,633 49,905 D
Open-market sales · 6,628 sh · avg $542.73 · $3,597,188

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-11-16 Exercise or conversion : show line 22 in the form Non-Qualified Stock Option (right to buy) −13,736 $30.63 2020-12-14 13,736 0 D
Loading xslF345X03/edgardoc.xml…